Concepedia

Xiaoxin Cai

XC

15

Publications

1.3K

Citations

14

H-Index

2002

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Xiamen University

Cardiff University

United States Military Academy

Wenzhou Medical University

Xiaoxin Cai is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, physiology, and health sciences.

ORCID

Top concepts

Publications per year

2002–2020

15

Publications

15

Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein

Xiaoyan Chu, Kelly Bleasby, Jocelyn Yabut et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 175 citations

Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide<scp>1B</scp>clinical probe than rosuvastatin

Thomayant Prueksaritanont, Xiaoyan Chu, Raymond Evers et al. · British Journal of Clinical Pharmacology · 2014 · 162 citations · Full text

Cytochrome P450 3A4-Mediated Bioactivation of Raloxifene:  Irreversible Enzyme Inhibition and Thiol Adduct Formation

Qing Chen, Jason S. Ngui, George A. Doss et al. · Chemical Research in Toxicology · 2002 · 156 citations

, , +20

Rifampin's Acute Inhibitory and Chronic Inductive Drug Interactions: Experimental and Model-Based Approaches to Drug–Drug Interaction Trial Design

Marc L. Reitman, Xiaoyan Chu, Xiaoxin Cai et al. · Clinical Pharmacology & Therapeutics · 2010 · 156 citations

Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2)

Xiaoyan Chu, John R. Strauss, Michele A. Mariano et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 141 citations

Rows per page

1–5 of 15